Goals and Consensus of Basic and Translational Research on Glioma during China’s 14th Five-Year Plan (2021—2025)

The “14th Five-Year Development Plan” (2021-2025) and the outline of long-term goals for 2035 in China put to priority the protection of people's health and construction of a “healthy China” in an all-round way.At present, the morbidity and mortality of nervous system tumors in China rank first in the world, which seriously threatens the health of the Chinese people.In this context, the basic and translational research group of Glioma Specialized Committee of the Chinese Medical Association reviewed and summarized the current research progress of glioma, focusing on the breakthroughs of new diagnostic and therapeutic strategies, the in-depth study of pathogenesis and drug resistance mechanisms, the development and exploration of new glioma animal models, and the establishment of glioma standardized resource sharing platform in China, so as to clarify the research direction of glioma in China, accelerate the translation from basic research to clinical application of glioma, and realize the overall pipeline layout of scientific research achievements from patent to clinical application.